Patent · US Active

Use of novel anti-HPV pharmaceutical preparation

US10045954B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

INSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF MEDICAL SCIENCES · CN

Inventors

Tianjun Liu · Albion, US
Shuai Meng · Tianjin, CN
Lihui Zhao · Shanghai, CN
Ge Hong · Tianjin, CN

Key dates

Filing date	Jul 14, 2014
Grant date	Aug 14, 2018
Priority date	—
Expiry date	Jul 14, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention discloses a use of paracetamol and a pharmaceutical preparation containing the same in preparation of anti-HPV drugs. The novel anti-HPV pharmaceutical preparation of the invention has a significant anti-HPV effect and low toxicity, and can be used for preventing and treating clinical symptoms caused by HPV infection, especially common warts, plane warts, plantar wart, vulvar cancer, penile neoplasms, anal carcinoma, prostate cancer, bladder cancer, cervical cancer, rectal cancer, oral cancer, tonsil cancer and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.